Tekton Research is pleased to share that its sites are part of Allucent’s newly launched IGNITE™ Site Network, a global network of pre-qualified clinical research sites designed to support greater speed, quality, and predictability in clinical trial delivery.
IGNITE brings together sites aligned around therapeutic expertise, defined execution commitments, and earlier site engagement. The network connects Sponsors with research sites across Allucent’s therapeutic Centers of Expertise, including neuroscience and cardiometabolic diseases, two areas closely aligned with Tekton’s ongoing research focus.
Tekton is excited to be part of the IGNITE Site Network and looks forward to continuing its work with Allucent as the network moves forward.
Read the full Allucent press release: Allucent Launches IGNITE™ Site Network to Enhance Speed, Quality, and Predictability Across Clinical Trial Delivery
